Updated Jul 16, 2026
Brady Kelly has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $444.
Brady Kelly is associated with Seres Therapeutics, Inc., a biotechnology company focused on developing therapies based on the human microbiome. Specific details about his role and contributions to the company are not widely documented, indicating he may not be a publicly prominent figure.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | MCRB | Seres Therapeutics, Inc. | S — Open-market sale | 59 | $7.53 | $444 |
| 2026-05-19 | MCRB | Seres Therapeutics, Inc. | M — Option exercise | 180 | — |
Brady Kelly is associated with Seres Therapeutics, Inc., a biotechnology company focused on developing therapies based on the human microbiome. Specific details about his role and contributions to the company are not widely documented, indicating he may not be a publicly prominent figure.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($444) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Brady Kelly profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.